ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (mCRPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01400555
Recruitment Status : Completed
First Posted : July 22, 2011
Last Update Posted : March 21, 2018
Sponsor:
Information provided by (Responsible Party):
Cougar Biotechnology, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 12, 2014
  Actual Study Completion Date : February 28, 2017